Your browser doesn't support javascript.
loading
Long-acting protein drugs for the treatment of ocular diseases.
Ghosh, Joy G; Nguyen, Andrew A; Bigelow, Chad E; Poor, Stephen; Qiu, Yubin; Rangaswamy, Nalini; Ornberg, Richard; Jackson, Brittany; Mak, Howard; Ezell, Tucker; Kenanova, Vania; de la Cruz, Elisa; Carrion, Ana; Etemad-Gilbertson, Bijan; Caro, Roxana Garcia; Zhu, Kan; George, Vinney; Bai, Jirong; Sharma-Nahar, Radhika; Shen, Siyuan; Wang, Yiqin; Subramanian, Kulandayan K; Fassbender, Elizabeth; Maker, Michael; Hanks, Shawn; Vrouvlianis, Joanna; Leehy, Barrett; Long, Debby; Prentiss, Melissa; Kansara, Viral; Jaffee, Bruce; Dryja, Thaddeus P; Roguska, Michael.
Afiliación
  • Ghosh JG; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Nguyen AA; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Bigelow CE; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Poor S; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Qiu Y; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Rangaswamy N; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Ornberg R; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Jackson B; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Mak H; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Ezell T; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Kenanova V; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • de la Cruz E; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Carrion A; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Etemad-Gilbertson B; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Caro RG; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Zhu K; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • George V; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Bai J; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Sharma-Nahar R; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Shen S; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Wang Y; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Subramanian KK; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Fassbender E; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Maker M; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Hanks S; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Vrouvlianis J; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Leehy B; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Long D; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Prentiss M; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Kansara V; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Jaffee B; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Dryja TP; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
  • Roguska M; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.
Nat Commun ; 8: 14837, 2017 03 23.
Article en En | MEDLINE | ID: mdl-28332616
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades de la Retina / Proteínas Recombinantes de Fusión / Receptores de Factores de Crecimiento Endotelial Vascular / Bevacizumab / Ranibizumab Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades de la Retina / Proteínas Recombinantes de Fusión / Receptores de Factores de Crecimiento Endotelial Vascular / Bevacizumab / Ranibizumab Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos